JP2023510544A5 - - Google Patents
Info
- Publication number
- JP2023510544A5 JP2023510544A5 JP2022542413A JP2022542413A JP2023510544A5 JP 2023510544 A5 JP2023510544 A5 JP 2023510544A5 JP 2022542413 A JP2022542413 A JP 2022542413A JP 2022542413 A JP2022542413 A JP 2022542413A JP 2023510544 A5 JP2023510544 A5 JP 2023510544A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- seq
- amino acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025097871A JP2025124904A (ja) | 2020-01-09 | 2025-06-11 | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958809P | 2020-01-09 | 2020-01-09 | |
| US202062958827P | 2020-01-09 | 2020-01-09 | |
| US62/958,827 | 2020-01-09 | ||
| US62/958,809 | 2020-01-09 | ||
| US202062967104P | 2020-01-29 | 2020-01-29 | |
| US202062967242P | 2020-01-29 | 2020-01-29 | |
| US62/967,104 | 2020-01-29 | ||
| US62/967,242 | 2020-01-29 | ||
| US202063064571P | 2020-08-12 | 2020-08-12 | |
| US202063064506P | 2020-08-12 | 2020-08-12 | |
| US63/064,571 | 2020-08-12 | ||
| US63/064,506 | 2020-08-12 | ||
| US202063112219P | 2020-11-11 | 2020-11-11 | |
| US202063112202P | 2020-11-11 | 2020-11-11 | |
| US63/112,219 | 2020-11-11 | ||
| US63/112,202 | 2020-11-11 | ||
| PCT/US2021/012630 WO2021142212A1 (en) | 2020-01-09 | 2021-01-08 | Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025097871A Division JP2025124904A (ja) | 2020-01-09 | 2025-06-11 | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510544A JP2023510544A (ja) | 2023-03-14 |
| JP2023510544A5 true JP2023510544A5 (https=) | 2023-10-31 |
| JP7696909B2 JP7696909B2 (ja) | 2025-06-23 |
Family
ID=74505354
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542413A Active JP7696909B2 (ja) | 2020-01-09 | 2021-01-08 | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
| JP2025097871A Pending JP2025124904A (ja) | 2020-01-09 | 2025-06-11 | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025097871A Pending JP2025124904A (ja) | 2020-01-09 | 2025-06-11 | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US12605444B2 (https=) |
| EP (1) | EP4087605A1 (https=) |
| JP (2) | JP7696909B2 (https=) |
| KR (1) | KR20220163354A (https=) |
| CN (2) | CN121221754A (https=) |
| AU (1) | AU2021205936A1 (https=) |
| BR (1) | BR112022013620A2 (https=) |
| CA (1) | CA3166989A1 (https=) |
| IL (1) | IL294387A (https=) |
| MX (1) | MX2022008572A (https=) |
| PH (1) | PH12022551648A1 (https=) |
| WO (1) | WO2021142212A1 (https=) |
| ZA (1) | ZA202310905B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7696909B2 (ja) * | 2020-01-09 | 2025-06-23 | ビリオン セラピューティクス，リミティド ライアビリティ カンパニー | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070054262A1 (en) * | 2003-03-28 | 2007-03-08 | Baker Denise M | Methods of identifying optimal variants of peptide epitopes |
| WO2008027394A2 (en) * | 2006-08-28 | 2008-03-06 | The Wistar Institute Of Anatomy And Biology | Constructs for enhancing immune responses |
| JP5745102B2 (ja) * | 2011-02-12 | 2015-07-08 | グローブイミューン，インコーポレイテッド | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 |
| GB201223386D0 (en) * | 2012-12-24 | 2013-02-06 | Immune Targeting Systems Its Ltd | Vaccine |
| EP2959915A1 (en) * | 2014-06-23 | 2015-12-30 | Institut Pasteur | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
| CN105367662B (zh) * | 2014-08-29 | 2021-03-12 | 汤正好 | 一种hbv相关的融合蛋白、其制备方法及其应用 |
| EP3439696A4 (en) * | 2016-04-06 | 2019-12-25 | University of Washington | THERAPEUTIC VACCINE AGAINST THE HEPATITIS B VIRUS (HBV) USING THE HBV CORE ANTIGEN |
| EP3490610A4 (en) | 2016-08-01 | 2020-05-20 | The Wistar Institute Of Anatomy And Biology | Compositions and methods of replication deficient adenoviral vectors for vaccine applications |
| DK4037708T3 (da) * | 2019-09-30 | 2024-09-30 | Gilead Sciences Inc | HBV-vacciner og fremgangsmåder til at behandle HBV |
| JP7696909B2 (ja) * | 2020-01-09 | 2025-06-23 | ビリオン セラピューティクス，リミティド ライアビリティ カンパニー | ヘルペスウイルス糖タンパク質ｄと融合したｂ型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 |
-
2021
- 2021-01-08 JP JP2022542413A patent/JP7696909B2/ja active Active
- 2021-01-08 BR BR112022013620A patent/BR112022013620A2/pt unknown
- 2021-01-08 MX MX2022008572A patent/MX2022008572A/es unknown
- 2021-01-08 WO PCT/US2021/012630 patent/WO2021142212A1/en not_active Ceased
- 2021-01-08 CN CN202511456350.3A patent/CN121221754A/zh active Pending
- 2021-01-08 KR KR1020227027069A patent/KR20220163354A/ko active Pending
- 2021-01-08 CN CN202180019813.3A patent/CN115335076B/zh active Active
- 2021-01-08 EP EP21703111.1A patent/EP4087605A1/en active Pending
- 2021-01-08 CA CA3166989A patent/CA3166989A1/en active Pending
- 2021-01-08 IL IL294387A patent/IL294387A/en unknown
- 2021-01-08 PH PH1/2022/551648A patent/PH12022551648A1/en unknown
- 2021-01-08 US US17/790,259 patent/US12605444B2/en active Active
- 2021-01-08 AU AU2021205936A patent/AU2021205936A1/en active Pending
- 2021-08-27 US US17/459,313 patent/US11291716B2/en active Active
-
2022
- 2022-02-24 US US17/679,356 patent/US11850282B2/en active Active
-
2023
- 2023-10-24 US US18/492,945 patent/US12290561B2/en active Active
- 2023-11-27 ZA ZA2023/10905A patent/ZA202310905B/en unknown
-
2025
- 2025-04-04 US US19/170,785 patent/US20250228934A1/en active Pending
- 2025-06-11 JP JP2025097871A patent/JP2025124904A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11229694B2 (en) | Vaccine against RSV | |
| KR102505354B1 (ko) | Rsv f 단백질 돌연변이체 | |
| JP2008529558A5 (https=) | ||
| JP2006187292A5 (https=) | ||
| IL200341A (en) | Method for the preparation of immunogenic particles containing influenza a m2e protein fused to hepatitis b virus core protein | |
| JP2018171063A5 (https=) | ||
| JP2006149406A5 (https=) | ||
| CA2299677A1 (en) | Preparation and use of recombinant influenza a virus m2 constructs and vaccines | |
| JP2009544333A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| CN107847575B (zh) | 用于猪生殖与呼吸综合症及猪圆环病毒相关疾病的疫苗组合物 | |
| JP2020536489A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| JP2023510544A5 (https=) | ||
| JP2025124904A5 (https=) | ||
| KR20180038557A (ko) | 타겟 폴리펩티드를 제시하기 위한 폴리펩티드 캐리어 및 이의 용도 | |
| JP2010535504A5 (https=) | ||
| JP2018533908A5 (https=) | ||
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| JP2025509352A5 (https=) | ||
| JP2003528614A5 (https=) | ||
| Bae et al. | Recombinant DNA and protein vaccines for foot-and-mouth disease induce humoral and cellular immune responses in mice | |
| JP2024534178A5 (https=) | ||
| JP2025514872A5 (https=) |